BRAVE ASSET MANAGEMENT INC - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 42 filers reported holding ONCOLYTICS BIOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRAVE ASSET MANAGEMENT INC ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q3 2023$54,927
+108.2%
25,000
+150.0%
0.02%
+112.5%
Q2 2023$26,377
-19.5%
10,000
-50.0%
0.01%
-27.3%
Q4 2022$32,772
+31.1%
20,0000.0%0.01%
-15.4%
Q3 2022$25,000
+25.0%
20,0000.0%0.01%
+44.4%
Q2 2022$20,000
-37.5%
20,0000.0%0.01%
-18.2%
Q1 2022$32,000
+14.3%
20,0000.0%0.01%
+37.5%
Q4 2021$28,000
-33.3%
20,0000.0%0.01%
-33.3%
Q3 2021$42,000
-23.6%
20,0000.0%0.01%
-25.0%
Q2 2021$55,000
+44.7%
20,000
+100.0%
0.02%
+23.1%
Q1 2021$38,00010,0000.01%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
Verition Fund Management LLC 408,838$695,0000.02%
Magnus Financial Group LLC 10,000$17,0000.00%
SCOTIA CAPITAL INC. 48,039$83,0000.00%
HUNTINGTON NATIONAL BANK 1,052$2,0000.00%
BANK OF AMERICA CORP /DE/ 367$1,0000.00%
WELLS FARGO & COMPANY/MN 642$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HOWE & RUSLING INC 105$00.00%
1832 Asset Management L.P. 5$00.00%
DEUTSCHE BANK AG\ 4,601$7,0000.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders